GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SINTX Technologies Inc (LTS:0A8S) » Definitions » ROE % Adjusted to Book Value

SINTX Technologies (LTS:0A8S) ROE % Adjusted to Book Value : -118.27% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SINTX Technologies ROE % Adjusted to Book Value?

SINTX Technologies's ROE % for the quarter that ended in Dec. 2024 was -143.11%. SINTX Technologies's PB Ratio for the quarter that ended in Dec. 2024 was 1.21. SINTX Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -118.27%.


SINTX Technologies ROE % Adjusted to Book Value Historical Data

The historical data trend for SINTX Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SINTX Technologies ROE % Adjusted to Book Value Chart

SINTX Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -58.51 -123.71 -456.44 -143.86

SINTX Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -381.64 -151.64 -204.20 -443.54 -118.27

Competitive Comparison of SINTX Technologies's ROE % Adjusted to Book Value

For the Medical Devices subindustry, SINTX Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SINTX Technologies's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SINTX Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SINTX Technologies's ROE % Adjusted to Book Value falls into.


;
;

SINTX Technologies ROE % Adjusted to Book Value Calculation

SINTX Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-174.07% / 1.21
=-143.86%

SINTX Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-143.11% / 1.21
=-118.27%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SINTX Technologies ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SINTX Technologies's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


SINTX Technologies Business Description

Traded in Other Exchanges
Address
1885 West 2100 South, Salt Lake City, UT, USA, 84119
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.

SINTX Technologies Headlines

No Headlines